Search
for

    Research 10 of 18

    1. Therapeutic Strategies to Target the Androgen Receptor Journal of Medicinal Chemistry · 2022 · 36 citations
    2. Clinical Translation of Targeted Protein Degraders Clinical Pharmacology & Therapeutics · 2023 · 40 citations
    3. NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders Journal of Medicinal Chemistry · 2025 · 45 citations
    4. Peptide-Based PROTACs: Transitioning from Static Paradigm to a Dynamic Landscape within Targeted Protein Degradation Bioconjugate Chemistry · 2026
    5. Evolving CRBN ligands enhance the drug-like properties of protein degraders Journal of Enzyme Inhibition and Medicinal Chemistry · 2026
    6. Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One Journal of Medicinal Chemistry · 2022 · 10 citations
    7. Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer Cancers · 2024
    8. Advancing Design Strategy of PROTACs for Cancer Therapy MedComm · 2025 · 4 citations
    9. PROTACs: A novel strategy for cancer drug discovery and development MedComm · 2023 · 44 citations
    10. Protein degradation: expanding the toolbox to restrain cancer drug resistance Journal of Hematology & Oncology · 2023 · 7 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →